On July 9, Twist Bioscience rose 5.5% in regular trading, trading at $94.83/share, with Turnover of $27.29 million.
Within the Biotechnology sector where Twist Bioscience belongs, individual stock performance showed notable divergence. Among individual stocks, BridgeBio Pharma up 15.59%, Alnylam Pharmaceuticals up 11.98%, AbbVie up 0.36%, Gilead Sciences down 1.31%, Ionis Pharmaceuticals down 19.24%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)